financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Bank OZK Q2 Earnings Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bank OZK Q2 Earnings Rise
Jul 17, 2025 1:43 PM

04:17 PM EDT, 07/17/2025 (MT Newswires) -- Bank OZK ( OZK ) reported Q2 earnings late Thursday of $1.58 per diluted share, up from $1.52 a year earlier.

Analysts polled by FactSet expected $1.53.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PepsiCo joins major US companies in tweaking DEI policies
PepsiCo joins major US companies in tweaking DEI policies
Feb 20, 2025
Feb 20 (Reuters) - PepsiCo ( PEP ) has joined the growing list of major U.S. companies that are making changes to their diversity, equity and inclusion programs as President Donald Trump pushes to dismantle the practice across the federal government and private sector. The Frito-Lay to 7Up maker will end DEI workforce representation goals and transition its chief DEI...
 -- Chorus Aviation Brief: National Forecasts 2025 free cash flow at $116 million, which equates to a Near 22% FCF yield based on the current share price
-- Chorus Aviation Brief: National Forecasts 2025 free cash flow at $116 million, which equates to a Near 22% FCF yield based on the current share price
Feb 20, 2025
03:21 PM EST, 02/20/2025 (MT Newswires) -- Price: 19.26, Change: +0.01, Percent Change: +0.05 ...
 Pfizer says it will end global development of hemophilia gene therapy Beqvez
Pfizer says it will end global development of hemophilia gene therapy Beqvez
Feb 20, 2025
Feb 20 (Reuters) - Pfizer ( PFE ) said on Thursday it will end global development of its hemophilia gene therapy, Beqvez, citing soft demand from patients and their doctors. Beqvez was approved in the U.S. last year, for the treatment of adults with moderate to severe hemophilia B. The company said the discontinuation was due to several reasons, including...
 BRIEF-Megan Holdings To Offer 2.5 Mln Ordinary Shares In IPO, says SEC Filing
BRIEF-Megan Holdings To Offer 2.5 Mln Ordinary Shares In IPO, says SEC Filing
Feb 20, 2025
Feb 20 (Reuters) - Megan Holdings Ltd: * MEGAN HOLDINGS LTD: TO OFFER 2.5 MILLION ORDINARY SHARES IN IPO- SEC FILING Source text: Further company coverage: ...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved